Laboratory of Human Nutrition, Institute of Food, Nutrition, and Health, ETH Zürich, Zurich, Switzerland.
Laboratory of Human Nutrition, Faculty of Agricultural Sciences, University of Abomey-Calavi, Cotonou, Benin.
Am J Clin Nutr. 2021 Jun 1;113(6):1657-1669. doi: 10.1093/ajcn/nqaa433.
Long-term isotopic dilution measurements of body iron may allow quantification of basal body iron balance and iron gains during an iron intervention with higher precision and accuracy than conventional iron indices.
We compared body iron balance before, during, and after oral iron supplementation in women in Benin and in Switzerland.
In prospective studies, Beninese (n = 11) and Swiss (n = 10) women previously labeled with stable iron isotopes were followed preintervention for 90-120 d, then received 50-mg iron daily for 90-120 d and were followed postintervention for 90-120 d. We used changes in blood isotopic composition to calculate iron absorption (Feabs), iron loss (Feloss), and net iron balance (Fegain).
Compliance with supplementation was >90%. In Benin, during the preintervention, intervention, and postintervention periods, Fe means ± SDs were as follows: 1) Feabs: 0.92 ± 1.05, 3.75 ± 2.07, and 0.90 ± 0.93 mg/d; 2) Feloss: 1.46 ± 1.95, 1.58 ± 1.57, and 1.84 ± 1.61 mg/d; and 3) Fegain: -0.55 ± 1.56 mg/d, 2.17 ± 1.81 mg/d, and -0.94 ± 1.13 mg/d. In Switzerland, the corresponding values were: 1) 1.51 ± 0.37, 4.09 ± 1.52, and 0.97 ± 0.41 mg/d; 2) 0.76 ± 1.37, 2.54 ± 1.43, and 2.08 ± 1.05 mg/d; and 3) 0.75 ± 1.37, 1.55 ± 1.75, and -1.11 ± 1.06 mg/d. Inflammation was low in both settings, and isotopically calculated iron balance was comparable to that calculated from changes in conventional iron indices.
Without iron supplementation, Beninese women had lower long-term dietary iron absorption and higher iron losses in the preintervention period than Swiss women. During iron supplementation, both groups had high iron absorption and similar iron gains. However, there was a 3-fold increase in iron losses in the Swiss women during the supplementation and postintervention period compared with the preintervention period. Body iron isotope dilution is a promising new method for quantifying long-term body iron balance and for assessing the impact of iron interventions. The studies were registered at clinicaltrials.gov as NCT02979080 and NCT02979132, respectively.
与传统铁指标相比,长期同位素稀释法测量体内铁可以更精确和准确地定量基础铁平衡和铁摄入。
我们比较了贝宁和瑞士妇女在口服铁补充期间、期间和之后的体内铁平衡。
在前瞻性研究中,11 名贝宁和 10 名瑞士女性以前用稳定的铁同位素标记,在干预前 90-120 天进行随访,然后每天接受 50 毫克铁,90-120 天进行随访,90-120 天进行随访。我们使用血液同位素组成的变化来计算铁吸收(Feabs)、铁损失(Feloss)和净铁平衡(Fegain)。
补充剂的依从性>90%。在贝宁,在干预前、干预中和干预后期间,Fe 的平均值±SD 如下:1)Feabs:0.92±1.05、3.75±2.07 和 0.90±0.93mg/d;2)Feloss:1.46±1.95、1.58±1.57 和 1.84±1.61mg/d;3)Fegain:-0.55±1.56mg/d、2.17±1.81mg/d 和-0.94±1.13mg/d。在瑞士,相应的值为:1)1.51±0.37、4.09±1.52 和 0.97±0.41mg/d;2)0.76±1.37、2.54±1.43 和 2.08±1.05mg/d;3)0.75±1.37、1.55±1.75 和-1.11±1.06mg/d。在两个环境中炎症均较低,同位素计算的铁平衡与从常规铁指标变化计算的铁平衡相当。
在没有铁补充的情况下,贝宁妇女在干预前的长期饮食铁吸收和铁损失均低于瑞士妇女。在铁补充期间,两组铁吸收均较高,铁增益相似。然而,与干预前相比,瑞士妇女在补充和干预后期间铁损失增加了 3 倍。身体铁同位素稀释是一种很有前途的新方法,可以定量长期的体内铁平衡,并评估铁干预的影响。这些研究分别在 clinicaltrials.gov 上注册为 NCT02979080 和 NCT02979132。